Sandesh Seth Net Worth & Insider Trades
Sandesh Seth - Chief Executive Officer, Actinium Pharmaceuticals, Inc
What is Sandesh Seth's Net Worth?
The current estimated net worth of Actinium Pharmaceuticals, Inc's Chief Executive Officer, Sandesh Seth, is estimated to be about $1.13M . Sandesh Seth owns about 153,333 units of Actinium Pharmaceuticals, Inc common stock. In the last 9 years at Actinium Pharmaceuticals, Inc, Sandesh Seth has sold an estimated value of $0 worth.
What is Sandesh Seth's Past Insider Trading?
Sandesh Seth's largest purchase order was 15,000 units , worth over $29.9K on April 18, 2016. In total, Sandesh Seth has made about 20 transactions over 9 years of their time at Actinium Pharmaceuticals, Inc. Sandesh Seth usually trades in August, with the busiest year in 2018 and 2017. The most recent transaction was a purchase order of 10,000 units , worth over $4.37K on December 10, 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sandesh Seth
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Sandesh Seth's' Mailing Address?
- Mailing address is 300 E 93rd Street, #20-B New York NY 10128 NY
What are Actinium Pharmaceuticals, Inc's Past Insider Trades?
Actinium Pharmaceuticals, Inc's most recent insider trade came on December 10, 2018 by Sandesh Seth who bought 10,000 units worth $4.37K . In the last 5 years, insiders at Actinium Pharmaceuticals, Inc have sold an estimated value of $2.28M and bought an estimated value of $315.67K worth of shares. Insider trading is most common in July, with the busiest year in 2016. The most active traders at the company are Sandesh Seth, Chief Executive Officer, Memorial Sloan-Kettering Cancer Center, and Richard Steinhart, Director .
Actinium Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |